Schedule 13G ownership disclosure

BIODEXA PHARMACEUTICALS PLC SPONSORED

Ordinary Shares, nominal value 0.00005 GBP per share · CUSIP: 59564R807

Event date: 2025-02-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • C/M Capital Master Fund, LP

    Shares: 0.00 · Class: 0%

  • C/M Capital Partners, LP

    Shares: 0.00 · Class: 0%

  • Thomas Walsh

    Shares: 0.00 · Class: 0%

  • Jonathan Juchno

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-001097
Form type
SCHEDULE 13G
Filer
Biodexa Pharmaceuticals Plc
CIK
CIK 1643918
Filed
Feb 18, 2025
Reporting period
Feb 10, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub